CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-08 | SHERMAN JEFFREY W Director | Grant or award | +15,000 | 65,378 | ||
| 2022-06-08 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-08 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award | +15,000 | $2.10 | $32K | 15,000 |
| 2022-06-08 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-08 | PERSKY MARLA Director | Grant or award | +15,000 | 15,000 | ||
| 2022-06-08 | PERSKY MARLA Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-08 | HALKUFF DAWN Director | Grant or award | +15,000 | 15,000 | ||
| 2022-06-08 | HALKUFF DAWN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-08 | Schmid John P. Director | Grant or award | +15,000 | 20,659 | ||
| 2022-06-08 | Schmid John P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-08 | JOHNSON JOHN Director | Grant or award | +15,000 | 493,312 | ||
| 2022-06-08 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-05-12 | Edick Paul R See Remarks | Purchase | +100,000 | $1.40 | $140K | 1,508,064 |
| 2022-02-22 | PRESTRELSKI STEVEN Chief Scientific Officer | Option exercise | +11,228 | $0.69 | $8K | 581,008 |
| 2022-02-22 | PRESTRELSKI STEVEN Chief Scientific Officer | Sale | −11,228 | $2.42 | $27K | 569,780 |
| 2022-02-22 | PRESTRELSKI STEVEN Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,228 | 0 | ||
| 2022-01-31 | Hecht Beth See Remarks | Shares withheld for taxes | −4,448 | $2.11 | $9K | 1,540,323 |
| 2022-01-31 | JOHNSON KENNETH ERLAND See Remarks | Shares withheld for taxes | −2,307 | $2.11 | $5K | 438,136 |
| 2022-01-31 | Pieper Steven See Remarks | Shares withheld for taxes | −750 | $2.11 | $2K | 1,622,702 |
| 2022-01-31 | Shannon John Patrick Jr See Remarks | Shares withheld for taxes | −7,497 | $2.11 | $16K | 2,396,423 |
Page 12 of 18 · 354 trades